ELVN - CIK 0001672619
Enliven Therapeutics, Inc. has filed 750 documents with the SEC between 2016 and 2026. The most frequent type is insider trade (309 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2023-11-06 | 2023-11-03 |
| Insider trade | 4 | 2023-10-03 | 2023-09-29 |
| Insider sale notice | 144 | 2023-09-29 | - |
| Insider trade | 4 | 2023-09-28 | 2023-09-26 |
| Insider trade | 4 | 2023-09-26 | 2023-09-25 |
| Insider sale notice | 144 | 2023-09-25 | - |
| Insider trade | 4 | 2023-08-28 | 2023-08-24 |
| Activist ownership stake (update) | SC 13D/A | 2023-08-28 | - |
| Insider sale notice | 144 | 2023-08-24 | - |
| Insider sale notice | 144 | 2023-08-24 | - |
| Quarterly report | 10-Q | 2023-08-10 | 2023-06-30 |
| Major company event | 8-K | 2023-08-10 | 2023-08-10 |
| Prospectus supplement | 424B5 | 2023-07-06 | - |
| EFFECT | - | 2023-07-03 | - |
| Company correspondence | CORRESP | 2023-06-29 | - |
| SEC correspondence | UPLOAD | 2023-06-29 | - |
| Major company event | 8-K | 2023-06-26 | 2023-06-23 |
| Securities registration | S-3 | 2023-06-23 | - |
| Major company event | 8-K | 2023-06-23 | 2023-06-23 |
| Insider trade | 4 | 2023-05-19 | 2023-05-17 |
| Insider trade | 4 | 2023-05-19 | 2023-05-17 |
| Major company event | 8-K | 2023-05-11 | 2023-05-11 |
| Quarterly report | 10-Q | 2023-05-11 | 2023-03-31 |
| Passive ownership stake | SC 13G | 2023-05-10 | - |
| Annual report to shareholders | ARS | 2023-04-28 | 2022-12-31 |
| Proxy materials | DEFA14A | 2023-04-28 | - |
| Proxy statement | DEF 14A | 2023-04-28 | 2023-06-23 |
| Passive ownership stake | SC 13G | 2023-04-27 | - |
| Passive ownership stake | SC 13G | 2023-04-24 | - |
| Insider trade | 4 | 2023-04-06 | 2023-04-04 |
| Insider trade | 4 | 2023-04-06 | 2023-04-04 |
| Insider trade | 4 | 2023-04-06 | 2023-04-04 |
| Insider trade | 4 | 2023-04-06 | 2023-04-04 |
| Insider trade | 4 | 2023-04-06 | 2023-04-04 |
| Insider trade | 4 | 2023-04-06 | 2023-02-23 |
| Insider trade | 4 | 2023-04-06 | 2023-02-23 |
| Insider trade | 4 | 2023-04-06 | 2023-02-23 |
| Insider trade | 4 | 2023-04-06 | 2023-02-23 |
| Insider trade | 4 | 2023-04-06 | 2023-02-23 |
| Insider trade | 4 | 2023-04-06 | 2023-02-23 |
| Insider trade | 4 | 2023-04-06 | 2023-02-23 |
| Major company event (amended) | 8-K/A | 2023-03-21 | 2023-02-23 |
| Passive ownership stake | SC 13G | 2023-03-13 | - |
| New insider ownership | 3 | 2023-03-06 | 2023-02-23 |
| Passive ownership stake | SC 13G | 2023-03-06 | - |
| Activist ownership stake | SC 13D | 2023-03-06 | - |
| Employee stock plan | S-8 | 2023-03-01 | - |
| Major company event | 8-K | 2023-03-01 | 2023-02-23 |
| Passive ownership stake (update) | SC 13G/A | 2023-02-28 | - |
| Activist ownership stake | SC 13D | 2023-02-28 | - |